These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38458271)

  • 41. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases.
    Ashok PW; Templeton A; Wagaarachchi PT; Flett GM
    BJOG; 2002 Nov; 109(11):1281-9. PubMed ID: 12452467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
    Goldberg AB; Fulcher IR; Fortin J; Hofer RK; Cottrill A; Dethier D; Gilbert A; Janiak E; Roncari D
    Obstet Gynecol; 2022 May; 139(5):771-780. PubMed ID: 35576336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens.
    Heikinheimo O; Leminen R; Suhonen S
    Contraception; 2007 Dec; 76(6):456-60. PubMed ID: 18061704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Consistency of medical abortion efficacy from 5 through 14 weeks' gestation.
    Garbin O; Vayssiere C; Bettahar-Lebugle K; Nisand I
    Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):36-40. PubMed ID: 16325992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How Effective Is Misoprostol Alone for Medication Abortion?
    Moseson H; Jayaweera R; Baum SE; Gerdts C
    NEJM Evid; 2024 Jun; 3(6):EVIDccon2300129. PubMed ID: 38804786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness and safety of early medication abortion provided in pharmacies by auxiliary nurse-midwives: A non-inferiority study in Nepal.
    Rocca CH; Puri M; Shrestha P; Blum M; Maharjan D; Grossman D; Regmi K; Darney PD; Harper CC
    PLoS One; 2018; 13(1):e0191174. PubMed ID: 29351313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concurrent use of mifepristone and misoprostol for early medical abortion.
    Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical outcomes of medication abortion using misoprostol-only: A retrospective chart review at an abortion provider organization in the United States.
    Raymond EG; Weaver MA; Shochet T; Grant M; Boyd K; Koenig LR; Upadhyay U
    Contraception; 2023 Oct; 126():110109. PubMed ID: 37390948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019.
    Aultman K; Cirucci CA; Harrison DJ; Beran BD; Lockwood MD; Seiler S
    Issues Law Med; 2021; 36(1):3-26. PubMed ID: 33939340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Self-administered versus provider-administered medical abortion.
    Gambir K; Kim C; Necastro KA; Ganatra B; Ngo TD
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013181. PubMed ID: 32150279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acceptability and feasibility of medical abortion in Nepal.
    Karki C; Pokharel H; Kushwaha A; Manandhar D; Bracken H; Winikoff B
    Int J Gynaecol Obstet; 2009 Jul; 106(1):39-42. PubMed ID: 19345944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion.
    Creinin MD; Potter C; Holovanisin M; Janczukiewicz L; Pymar HC; Schwartz JL; Meyn L
    Am J Obstet Gynecol; 2003 Mar; 188(3):664-9. PubMed ID: 12634638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial.
    Ngoc NTN; Shochet T; Raghavan S; Blum J; Nga NTB; Minh NTH; Phan VQ; Winikoff B
    Obstet Gynecol; 2011 Sep; 118(3):601-608. PubMed ID: 21860289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy.
    Shah D; Rijal P; Thakur A; Rai R
    JNMA J Nepal Med Assoc; 2018; 56(213):856-860. PubMed ID: 31065120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pilot study on the combined use of letrozole, mifepristone and misoprostol in termination of first trimester pregnancy up to 9 weeks' gestation.
    Chai J; Ho PC
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):291-4. PubMed ID: 24135383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of mifepristone-buccal misoprostol for early medical abortion in an Australian clinical setting.
    Goldstone P; Walker C; Hawtin K
    Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):366-371. PubMed ID: 28303569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.